Currently, it is diagnosed by the presence of anti-GFAP autoantibodies in CNS. Detection of<unk> -IgG in CSF by IFA and confirmation by<unk> α-CBA is recommended.
Autoimmune GFAP astrocytopathy
Anti-NMDA receptor encephalitis
Pantothenate kinase-associated neurodegeneration
Anti-Hu associated encephalitis
Anti-neurofascin demyelinating diseases
Glial tumor
Anti-VGKC-complex encephalitis
Hereditary CNS demyelinating disease